{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:13:32Z","timestamp":1790716412184,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30872510"],"award-info":[{"award-number":["30872510"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81272534"],"award-info":[{"award-number":["81272534"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.heliyon.2024.e37588","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T18:25:49Z","timestamp":1725647149000},"page":"e37588","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hormone replacement therapy and risk of pancreatic cancer in postmenopausal women: Evidence from the US National Inpatient Sample 2008\u20132018"],"prefix":"10.1016","volume":"10","author":[{"given":"Lei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dekai","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruirui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibing","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.heliyon.2024.e37588_bib1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","article-title":"Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors","volume":"18","author":"Klein","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"43","key":"10.1016\/j.heliyon.2024.e37588_bib2","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.3748\/wjg.v24.i43.4846","article-title":"Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes","volume":"24","author":"McGuigan","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37588_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-73525-y","article-title":"The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data","volume":"10","author":"Bengtsson","year":"2020","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e37588_bib4","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S2468-1253(19)30347-4","article-title":"The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"4","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37588_bib5","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1001\/jama.2019.10232","article-title":"Screening for pancreatic cancer: US preventive services task force reaffirmation recommendation statement","volume":"322","author":"Owens","year":"2019","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37588_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10061284","article-title":"Obesity and pancreatic cancer: recent progress in epidemiology, mechanisms and bariatric surgery","volume":"10","author":"Shinoda","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.heliyon.2024.e37588_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103996","article-title":"Uniting epidemiology and experimental models: pancreatic steatosis and pancreatic cancer","volume":"79","author":"Truong","year":"2022","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37588_bib8","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37588_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006136","article-title":"Phase Ib open-label, multicenter study of pixatimod, an activator of TLR9, in combination with nivolumab in subjects with microsatellite-stable metastatic colorectal cancer, metastatic pancreatic ductal adenocarcinoma and other solid tumors","volume":"11","author":"Lemech","year":"2023","journal-title":"J Immunother Cancer"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37588_bib10","doi-asserted-by":"crossref","first-page":"705","DOI":"10.21147\/j.issn.1000-9604.2020.06.04","article-title":"Current epidemiology of pancreatic cancer: challenges and opportunities","volume":"32","author":"Luo","year":"2020","journal-title":"Chin. J. Cancer Res."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37588_bib11","doi-asserted-by":"crossref","DOI":"10.1080\/08941939.2022.2129884","article-title":"Pancreatic cancer: a review of current treatment and novel therapies","volume":"36","author":"Kolbeinsson","year":"2023","journal-title":"J. Invest. Surg."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37588_bib12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14740\/wjon1166","article-title":"Epidemiology of pancreatic cancer: global trends, etiology and risk factors","volume":"10","author":"Rawla","year":"2019","journal-title":"World J. Oncol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37588_bib13","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s00595-020-02120-5","article-title":"Minimally invasive surgery for pancreatic cancer","volume":"51","author":"Miyasaka","year":"2021","journal-title":"Surg. Today"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e37588_bib14","first-page":"1723","article-title":"Pancreatitis and pancreatic cancer in two large pooled case-control studies","volume":"20","author":"Bracci","year":"2009","journal-title":"Cancer Causes Control"},{"issue":"27","key":"10.1016\/j.heliyon.2024.e37588_bib15","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.3748\/wjg.v27.i27.4298","article-title":"Pancreatic cancer: a review of epidemiology, trend, and risk factors","volume":"27","author":"Hu","year":"2021","journal-title":"World J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e37588_bib16","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.annonc.2022.03.276","article-title":"The age-dependent association of risk factors with pancreatic cancer","volume":"33","author":"Yuan","year":"2022","journal-title":"Ann. Oncol."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e37588_bib17","first-page":"2332","article-title":"Inhibitory effects of estrogen and castration on the early stage of pancreatic carcinogenesis in Fischer rats treated with azaserine","volume":"49","author":"Sumi","year":"1989","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37588_bib18","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jcmgh.2020.04.016","article-title":"Pharmacologic activation of the G protein-coupled estrogen receptor inhibits pancreatic ductal adenocarcinoma","volume":"10","author":"Natale","year":"2020","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"20","key":"10.1016\/j.heliyon.2024.e37588_bib19","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1001\/jama.2021.18859","article-title":"Incidence of pancreatic cancer by age and sex in the US, 2000-2018","volume":"326","author":"Gaddam","year":"2021","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37588_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15030870","article-title":"Pancreatic cancer incidence trends by race, ethnicity, age and sex in the United States: a population-based study, 2000-2018","volume":"15","author":"Samaan","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.heliyon.2024.e37588_bib21","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1210\/jc.2009-2509","article-title":"Postmenopausal hormone therapy: an endocrine society scientific statement","volume":"95","author":"Santen","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.heliyon.2024.e37588_bib22","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/aje\/kwx388","article-title":"Oral contraceptive use and risks of cancer in the NIH-AARP diet and health study","volume":"187","author":"Michels","year":"2018","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.heliyon.2024.e37588_bib23","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/CEJ.0000000000000358","article-title":"Female reproductive factors, exogenous hormone use, and pancreatic cancer risk: the Japan Public Health Center-based prospective study","volume":"26","author":"Teng","year":"2017","journal-title":"Eur. J. Cancer Prev."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37588_bib24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/ijc.31302","article-title":"Hormonal factors and pancreatic cancer risk in women: the Malm\u00f6 Diet and Cancer Study","volume":"143","author":"Andersson","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.heliyon.2024.e37588_bib25","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1177\/2050640617702060","article-title":"Menopausal hormone therapy and pancreatic cancer risk in women: a population-based matched cohort study","volume":"5","author":"Sadr-Azodi","year":"2017","journal-title":"United Eur. Gastroenterol. J."},{"key":"10.1016\/j.heliyon.2024.e37588_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206358","article-title":"Hormonal contraceptive use and risk of pancreatic cancer\u2014a cohort study among premenopausal women","volume":"13","author":"Butt","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e37588_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canep.2017.05.002","article-title":"Reproductive factors, exogenous hormone use, and risk of pancreatic cancer in postmenopausal women","volume":"49","author":"Kabat","year":"2017","journal-title":"Cancer Epidemiol"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37588_bib28","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1001\/jamasurg.2018.0542","article-title":"Practical guide to surgical data sets: Healthcare Cost and utilization project national inpatient sample (NIS)","volume":"153","author":"Stulberg","year":"2018","journal-title":"JAMA Surg"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e37588_bib29","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/aje\/kwt154","article-title":"Reproductive factors, exogenous hormones, and pancreatic cancer risk in the CTS","volume":"178","author":"Lee","year":"2013","journal-title":"Am. J. Epidemiol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e37588_bib30","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1097\/MPA.0000000000000635","article-title":"Menstrual and reproductive factors, hormone use, and risk of pancreatic cancer: analysis from the international pancreatic cancer case-control consortium (PanC4)","volume":"45","author":"Lujan-Barroso","year":"2016","journal-title":"Pancreas"},{"key":"10.1016\/j.heliyon.2024.e37588_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canep.2017.05.002","article-title":"Reproductive factors, exogenous hormone use, and risk of pancreatic cancer in postmenopausal women","volume":"49","author":"Kabat","year":"2017","journal-title":"Cancer Epidemiol"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37588_bib32","first-page":"473","article-title":"A case-control study of reproductive factors, female hormone use, and risk of pancreatic cancer","volume":"21","author":"Zhang","year":"2010","journal-title":"Cancer Causes Control"},{"issue":"23","key":"10.1016\/j.heliyon.2024.e37588_bib33","first-page":"6687","article-title":"Inhibition of a transplantable pancreatic carcinoma by castration and estradiol administration in rats","volume":"49","author":"Sumi","year":"1989","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37588_bib34","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.bbrc.2016.04.049","article-title":"17\u03b2-estradiol exerts anticancer effects in anoikis-resistant hepatocellular carcinoma cell lines by targeting IL-6\/STAT3 signaling","volume":"473","author":"Lee","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37588_bib35","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2174\/1574892817666211222150409","article-title":"\u03b2-Estradiol induces mitochondrial apoptosis in cervical cancer through the suppression of AKT\/NF-\u03baB signaling pathway","volume":"17","author":"Huang","year":"2022","journal-title":"Recent Pat. Anti-Cancer Drug Discov."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e37588_bib36","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41416-019-0562-y","article-title":"Antihypertensive drugs and pancreatic cancer risk in patients with chronic pancreatitis: a Danish nationwide population-based cohort study","volume":"121","author":"Kirkeg\u00e5rd","year":"2019","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37588_bib37","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/17474124.2022.2088506","article-title":"The relationships between antihypertensive medications and the overall survival of patients with pancreatic cancer: a systematic review and meta-analysis","volume":"16","author":"Jiang","year":"2022","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37588_bib38","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1186\/s12885-023-11344-w","article-title":"Association between pancreatic cancer and diabetes: insights from a retrospective cohort study","volume":"23","author":"Amri","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.heliyon.2024.e37588_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2021.06.027","article-title":"Advances in the epidemiology of pancreatic cancer: trends, risk factors, screening, and prognosis","volume":"520","author":"Cai","year":"2021","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37588_bib40","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3892\/ol.2017.5572","article-title":"Statins and pancreatic cancer","volume":"13","author":"Gong","year":"2017","journal-title":"Oncol. Lett."},{"issue":"22","key":"10.1016\/j.heliyon.2024.e37588_bib41","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.3390\/nu14224938","article-title":"Temporal association of total serum cholesterol and pancreatic cancer incidence","volume":"14","author":"Wang","year":"2022","journal-title":"Nutrients"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024136195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024136195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:25:30Z","timestamp":1790713530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024136195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":41,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2405844024136195"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37588","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hormone replacement therapy and risk of pancreatic cancer in postmenopausal women: Evidence from the US National Inpatient Sample 2008\u20132018","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37588","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e37588"}}